MedTrace Logo

NSAIDs in Sciatica NSAIDS IN SCIATICA

NCT03347929 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2023-10-05

No results posted yet for this study

Summary

This study will evaluate whether treatment with Naproxen 500 mg twice daily is superior to placebo for the improvement of leg pain in patients with sciatica. Half of patients will receive Naproxen while the other half will receive placebo.

Conditions

  • Sciatica

Interventions

DRUG

Naproxen 500 Mg

10 days treatment with Naproxen 500 mg twice daily

DRUG

Placebo

10 days treatment with Placebo1 tablet twice daily

Sponsors & Collaborators

  • Vestre Viken Hospital Trust

    collaborator OTHER

  • Sykehuset Telemark

    collaborator OTHER_GOV

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • Oslo University Hospital

    collaborator OTHER

  • Ostfold Hospital Trust

    lead OTHER

Principal Investigators

  • Waleed Ghanima, MD,PhD · Ostfold Hospital Trust

  • Anne Haugen, MD,PhD · Ostfold Hospital Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-30
Primary Completion
2023-06-22
Completion
2023-06-22

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03347929 on ClinicalTrials.gov